Day 2: Thursday, September 24
Day 2: Thursday, September 24
08:00 - 08:3030 mins
Morning Registration & Breakfast
08:30 - 08:4515 mins
INNOVATION SPOTLIGHT
Pioneering A Once-Daily Oral HSD-1 Inhibitor For Intracellular Regulation of Cortisol in Cardiometabolic disease
08:45 - 09:0015 mins
INNOVATION SPOTLIGHT
Small Molecule Agonism of the Apelin Pathway as a Novel Exercise Mimetic Strategy
- Peng Leong - CBO, BioAge Labs
09:00 - 09:1515 mins
INNOVATION SPOTLIGHT
Spotlight Presentation Opportunity Available
09:15 - 09:3015 mins
INNOVATION SPOTLIGHT
A Novel Oral Glucose-Based Approach to Restore Nutrient Sensing and Neuroendocrine Signaling in Obesity
- Steffen-Sebastian Bolz - CSO, Aphaia Pharma AG
09:30 - 09:4515 mins
INNOVATION SPOTLIGHT
The Missing Biology of Weight Regain - The Next Category in Obesity Therapeutics
09:45 - 10:0015 mins
INNOVATION SPOTLIGHT
Spotlight Presentation Opportunity Available
10:00 - 10:1515 mins
INNOVATION SPOTLIGHT
Leveraging Site-Specific Modifications to Create Next Generation GLP-1 Peptides
- Saleha Patel - Head of Pipeline and Commercialization Strategy, Constructive Bio
10:15 - 10:4530 mins
Morning Refreshment Break
10:45 - 11:1530 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Oral Selective Androgen Receptor Modulation for Muscle Preservation in GLP-1 Patients
- Gary Barnette - CSO, Veru
11:15 - 11:4530 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
A Precision Antibody Approach to Maximise Weight-Loss and Muscle Mass Preservation
- Tom Hsu - Scientist, Ibio
11:45 - 12:1530 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Spotlight Presentation Opportunity Available
12:15 - 12:4530 mins
IN FOCUS: MUSCLE PRESERVING THERAPEUTICS
Investigating Anti-Myostatin + Anti-Activin A for Obesity: Update From Phase 2 COURAGE Trial
12:45 - 14:0075 mins
Lunch Break
14:00 - 14:3030 mins
GLP-1s BEYOND OBESITY
Future Role of GLP-1-Based Therapeutics in Neuroprotection
- Paul Edison - Professor of Neuroscience, UCL
14:30 - 15:0030 mins
GLP-1s BEYOND OBESITY
Exploring Future Applications of Incretin-based Therapies For Women’s Health
15:00 - 15:3030 mins
GLP-1s BEYOND OBESITY
Pioneering GLP-1 Analogs for Full-Joint Treatment of Osteoarthritis
15:30 - 16:0030 mins
Afternoon Refreshment Break
16:00 - 16:4040 mins
CLOSING KEYNOTE PLENARY
Keynote Panel: Breaking Barriers: Addressing Pricing and Reimbursement Challenges in Obesity Therapeutics
- Mimoun Ayoub, PhD - Senior VP, Global Head of Peptide and Oligonucleotide Platforms, CordenPharma International
- Kevin Xie - CFO, CORXEL
16:40 - 16:455 mins
CLOSING KEYNOTE PLENARY
Chair Closing Remarks
16:45 - 16:505 mins
Close of Obesity Science & Innovation 2026
16:50 - 18:50120 mins
2026 BWB Museum of Science Networking Party
Museum of Science Boston Networking Party
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。